Categories
Generic Drugs Healthcare Healthcare IT Medical Medical Devices Pharmaceuticals Uncategorized

Lyme Disease Diagnostics Market 2022- Outlook, Driving Force and Opportunities Analysis

Worldwide Lyme Disease Diagnostics Market is expected to display rising growth in forthcoming years. The Lyme disease is an infectious disease caused by bacterial infections. It is caused by the bacterial species boreliaburgodorferi and spread forth by vector xodex scapular. Lyme disease is the most common vector-borne illness in United States and its incidence is increasing manifold. The Lyme disease is a tick-borne disease and ticks are carriers of this disease. Ticks bite is enough for the infected person to become a carrier of this disease.

View Full TOC of This Report @ https://www.millioninsights.com/industry-reports/lyme-disease-diagnostics-market

 

By emerging technologies, segmentation for lyme disease diagnostic market includes molecular diagnostics, monoclonal antibodies, immunoasays, differential light scattering, liposomes, artificial intelligence, flow cytometry, information technology, gel microdroplets, chromatography and others. By geographical regions, segmentation for lyme disease diagnostics industry includes North America, Europe, Asia Pacific, MEA, and Latin America.

 

The end-user segment comprises hospitals, commercial labs/private labs, public health labs and physicians. There are numerous laboratories to check for tick bite and one of them is serological test, Serological test comprises Elisa and Western blot. The various other tests include urine antigen tests, lymphocytic transformation tests, immunofluorescent staining and PCR tests.

 

Routine blood tests samples are used to determine Lyme disease diagnostics and they are understandably good when blood tests help to rectify the problems associated with non-accurate serology based tests. North America accounts for major share in the Lyme disease diagnostics industry due to common occurrence of tick diseases in region. Europe and Asia markets go strong on the back of increasing patients suspected with Lyme disease diagnostics. The key players in lyme disease diagnostics market include Abbott Laboratories, Affeymetrics, Inc., Bio-Rad and Roche Diagnostics.

 

Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/lyme-disease-diagnostics-market/request-sample